Title: FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study
Authors: Geva, Ravit ×
Vecchione, Loredana
Kalogeras, Konstantinos T
Vittrup Jensen, Benny
Lenz, Heinz-Josef
Yoshino, Takayuki
Paez, David
Montagut, Clara
Souglakos, John
Cappuzzo, Federico
Cervantes, Andrés
Frattini, Milo
Fountzilas, George
Johansen, Julia S
Høgdall, Estrid Vilma
Zhang, Wu
Yang, Dongyun
Yamazaki, Kentaro
Nishina, Tomohiro
Papamichael, Demetris
Vincenzi, Bruno
Macarulla, Teresa
Loupakis, Fotios
De Schutter, Jef
Spindler, Karen Lise Garm
Pfeiffer, Per
Ciardiello, Fortunato
Piessevaux, Hubert
Tejpar, Sabine #
Issue Date: Jun-2015
Publisher: BMJ Publishing Group
Series Title: Gut vol:64 issue:6 pages:921-8
Article number: gutjnl-2014-307234
Abstract: We aimed to better clarify the role of germline variants of the FCG2 receptor, FCGR2A-H131R and FCGR3A-V158F, on the therapeutic efficacy of cetuximab in metastatic colorectal cancer (mCRC). A large cohort with sufficient statistical power was assembled.
ISSN: 0017-5749
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Molecular Digestive Oncology (+)
KCE TM K (-)
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science